Summary of the Article: Age & Sepsis – A New Approach to Treatment
This article details research led by Janelle Ayres, PhD, focusing on disease tolerance – the body’s ability to mitigate damage during infection, rather than solely focusing on killing the pathogen. Her team’s recent study reveals crucial differences in how young and old mice respond to sepsis, offering potential new avenues for treatment, especially in the face of growing antibiotic resistance.
Key takeaways:
* Sepsis is a dangerous overreaction of the immune system: It can led to multi-organ failure and death, even after the infection is cleared. Current treatments (antibiotics & anti-inflammatories) have limitations.
* Disease tolerance offers a new approach: Instead of just fighting the infection,focusing on minimizing the body’s own damaging response could be more effective.
* Age dramatically impacts disease tolerance: Young and old mice utilize different mechanisms to survive sepsis.
* Foxo1/Trim63/MuRF1 are key players: In young mice, these proteins protect the heart and prevent organ damage. However,in older mice,thay worsen outcomes. deleting Foxo1 actually improved survival in older mice.
* antibiotic resistance is a major threat: The research is particularly relevant given the escalating crisis of antibiotic resistance,highlighting the need for alternative treatment strategies.
In essence, the study suggests that a “one-size-fits-all” approach to sepsis treatment is insufficient.Treatments need to be tailored to the patient’s age and the specific mechanisms their body is using to cope with the infection. Ayres’ lab is working to identify these mechanisms to develop more targeted and effective therapies.
